An observational study in Surgical Fatigue, sponsored by Lancaster University. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-26.
Sponsored by Lancaster University · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 65 studies in Fatigue with a site in United Kingdom — 13 open to participants now, 16 under way, 2 of them phase 3. Fatigue · United Kingdom.
Among the 65 studies in Fatigue with a site in United Kingdom, this one is the 18th largest by enrollment of the 18 observational ones that give a count, is one of 5 that started in 2025, is one of 18 observational ones, and was the 53rd registered.
2,234 studies on the registry are indexed under Fatigue; 430 are open to participants now.
Browse Fatigue studies →13 of the 65 studies in Fatigue with a site in United Kingdom are open now. Recruiting first, the newest first:
University of Surrey · Sites in United Kingdom
Ages 18+
Oxford Brookes University · Sites in United Kingdom
Ages 18–80 · Healthy volunteers
Novartis Pharmaceuticals · Sites in United Kingdom, United States, Australia and 17 more countries
Ages 18+
Imperial College London · Sites in United Kingdom
Ages 18+
Loughborough University · Sites in United Kingdom
Ages 35–65 · Women only · Healthy volunteers
A study can be open while its sites in United Kingdom have not opened yet or have stopped. Only those recruiting at a site in United Kingdom →
Of the 242 Fatigue studies recruiting now, 113 (47%) set no upper age limit and 99 (41%) stop at 75 or younger; 23 take children under 18; 74 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
65 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 9 · Phase 3 4
First in 2005; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 9 is below the median of 99 across 406 observational studies indexed under Fatigue.
Median enrollment 60 across the 47 interventional studies, 62 across the 18 observational. Of the 41 that completed or were terminated, 3 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
9 of 65 have an industry lead sponsor. The 10 most frequent:
Lancaster University is the lead sponsor of 21 studies on the registry; 4 are open to participants now.
Lancaster University has 5 studies filed under Fatigue — fewer than ten, so there is no comparison to draw.
5 of the studies in Fatigue with a site in United Kingdom that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06770335Great Ormond Street Hospital for Children NHS Foundation TrustThe FLaME Cognitive Rehabilitation Study for Childhood Brain Tumour | 2026-12-31 |
| NCT07874217Oxford Brookes UniversityWhole-body Cryotherapy in Those With Chronic Fatigue: A Feasibility Study | 2027-01-08 |
| NCT07752329Northumbria UniversityInvestigation on the Chronic Effects of Nepalese Pepper (Zanthoxylum Armatum DC) on Cognitive Function, Mood and Gaming Performance in Young, Healthy, Action Video Gamers | 2027-05-01 |
| NCT07914647Sheffield Teaching Hospitals NHS Foundation TrustRemote Ischaemic Conditioning for Fatigue After Stroke 2 (RICFAST 2) | 2027-10-31 |
| NCT07940920University of SurreyA Personalised Anti-fatigue Program for Community-dwelling People With Chronic Lymphocytic Leukaemia | 2027-11-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 65 studies in Fatigue with a site in United Kingdom, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Surgeons are performing an increasing number of minimal access procedures because these offer certain advantages including improved recovery times. However, this also results in surgeons operating for longer periods which inevitably increases the already known prevalence of work-related Musculoskeletal (MSK) injuries amongst surgeons. Work-related MSK disorders account for 26 - 47.5% of illnesses and injuries due to overexertion and repetitive use, in professionals with ergonomically challenging jobs. Robotic-assisted laparoscopic surgery (RALS) is a modern technology that could help mitigate these MSK problems and thereby improve patient care. In comparison to standard laparoscopic surgery (LS), RALS offers steadier wrist movements with a reduced fulcrum effect, thus benefiting the patient.
No study has compared the demands of RALS vs. LS on musculoskeletal fatigue (and subsequent injury risk). The investigators need to determine whether a career using RALS is associated with better musculoskeletal health of surgeons than standard LS when performing complex minimally invasive procedures.
The study will recruit Surgeons who perform prostate and bowel surgical procedures who have experience using RALS and/or LS. Surgeons will complete a series of validated questionnaires before and after each surgery to subjectively determine musculoskeletal strain/pain and will have body composition quantified.
They will be fitted with EMG (to measure muscle fatigue) whilst performing real-life surgery. Analysis of data gathered will be used to show what the short- and long- term musculoskeletal demands are and in turn determine if these are associated with changes in motor control.
The researcher's postulated hypothesis is that RALS should have less musculoskeletal effects both short and long term on surgeons, therefore, highlighting the fact that the implementation of RALS should be less controversial, because in the long run, the most expensive objects in the operating room are the personnel.
Healthy, adult laparoscopic and robot- assisted laparoscopic surgeons.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Surgeons performing robot assisted laparoscopic surgery.
Other: No Interventions
Surgeons performing manual laparoscopic surgery.
Other: No Interventions
Observational study.
Acute muscle activation- percentage of forearm maximal voluntary contraction (%) assessed using EMG frequency.
This outcome measures the immediate impact of RALS and LS on the surgeon's forearm muscles during a single surgical procedure. It will be quantified by assessing the change in electromyography (EMG) frequency and amplitude recorded during clinically important surgical tasks within the surgeons' first surgery of the day. The contributing measures to this primary measure are the maximal voluntary contraction that will be assessed just before the surgery begins, and the average frequency of muscle activation (mV) over the 2 minute data collection period. Muscle activation for RALS and LS will be compared using this measure.
Time frame: Intraoperative
Surgeon musculoskeletal health over the last 12 months (Standardized Nordic Questionnaire)
This questionnaire assesses musculoskeletal symptoms experienced by the surgeons within the last 12 months. It helps to understand the prevalence and location of pain and discomfort before they participate in the study. This questionnaire primarily yields categorical data. For each of the nine body regions (neck, shoulders, upper back, elbows, low back, wrists/hands, hips/thighs, knees, ankles/feet), it asks about trouble (ache, pain, discomfort) in the past 12 months and in the past 7 days. It also asks if the trouble prevented normal work (at home or away from home).
Time frame: Preoperative
Surgeon physical activity participation status (International Physical Activity Questionnaire
The frequency, duration, and intensity of different types of physical activities (vigorous, moderate, walking, and sitting) undertaken by the surgeons. It aims to quantify their overall physical activity level. Can be reported as continuous scores (Metabolic Equivalent of Task - minutes per week, or MET-min/week) calculated by multiplying duration, frequency, and standard MET intensity values for each activity type. It can also be categorized into low, moderate, and high physical activity levels based on specific criteria related to frequency, duration, and total MET-min/week.
Time frame: Preoperative
Surgeon well-being and quality of life (SF36 Health and Wellbeing Questionnaire)
This assesses the surgeon's health-related quality of life across eight dimensions: Physical Functioning, Role Limitations due to Physical Health Problems, Bodily Pain, General Health Perceptions, Vitality (energy/fatigue), Social Functioning, Role Limitations due to Emotional Problems,1 and Mental Health (emotional well-being). This yields eight scaled scores ranging from 0 to 100, with higher scores indicating better health status in each dimension. Scoring involves recoding items, summing within scales, and then transforming to the standardized range using specific algorithms. Summary scores (PCS and MCS) can also be calculated.
Time frame: Preoperative
Maximal Voluntary Contraction measured using EMG (mV)
This will take place with the surgeon producing the a maximal contraction for both their forearm muscles and neck muscles in to create a baseline of comparison to calculate the percentage of maximal contraction that the surgeons experience during surgery.
Time frame: Intraoperative
Acute muscle activation- percentage of sternocleidomastoid maximal voluntary contraction (%) assesed using EMG frequency.
This outcome measures the immediate impact of RALS and LS on the surgeon's sternocleidomastoid muscles during a single surgical procedure. It will be quantified by assessing the change in electromyography (EMG) frequency and amplitude recorded during clinically important surgical tasks within the surgeons' first surgery of the day. The contributing measures to this primary measure are the maximal voluntary contraction that will be assessed just before the surgery begins, and the average frequency of muscle activation (mV) over the 2 minute data collection period. Muscle activation for RALS and LS will be compared using this measure.
Time frame: Intraoperative
Average sternocleidomastoid and forearm muscle EMG amplitude (mV)
This will be measured using EMG at clinically significant points in the surgery. This will allow for the researchers to assess the muscular demand and the amplitude and frequency of the EMG signal are the direct measures used to quantify this primary variable. Lower amplitude means a greater muscular demand.
Time frame: Intraoperative
Average sternocleidomastoid and forearm muscle EMG frequency (Hz).
This will be measured using EMG at clinically significant points in the surgery. This will allow for the researchers to assess the muscular demand and the amplitude and frequency of the EMG signal are the direct measures used to quantify this primary variable. Higher frequency means greater muscular demand.
Time frame: Intraoperative
Surgeon musculoskeletal health over the last 12 months (Standardized Nordic Questionnaire)
This questionnaire assesses musculoskeletal symptoms experienced by the surgeons within the last 12 months. It helps to understand the prevalence and location of pain and discomfort before they participate in the study. This questionnaire primarily yields categorical data. For each of the nine body regions (neck, shoulders, upper back, elbows, low back, wrists/hands, hips/thighs, knees, ankles/feet), it asks about trouble (ache, pain, discomfort) in the past 12 months and in the past 7 days. It also asks if the trouble prevented normal work (at home or away from home).
Time frame: Any time between enrolment in the study and the date of the surgical procedure that the data collection will take place.
Plan to share: Undecided — Only IPD in the published results will potentially be included.
Ran from May 2025 to primary completion in Sep 2025, 4 months.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Lancaster University